Mary Elizabeth Lynch

Summary

Affiliation: Dalhousie University
Country: Canada

Publications

  1. ncbi Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design
    Mary Elizabeth Lynch
    Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
    Pain 103:111-7. 2003
  2. ncbi A review of the use of methadone for the treatment of chronic noncancer pain
    Mary E Lynch
    Pain Managemaent Unit, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
    Pain Res Manag 10:133-44. 2005
  3. ncbi Compound heterozygosity in sodium channel Nav1.7 in a family with hereditary erythermalgia
    Mark E Samuels
    Département de Médicine, Centre de Recherche du CHUM, Local M 5226, Hopital Notre Dame, 1560 rue Sherbrooke Est, Montreal QC H2L 4M1, Canada
    Mol Pain 4:21. 2008
  4. ncbi Antidepressants as analgesics: a review of randomized controlled trials
    M E Lynch
    Queen Elizabeth II Health Sciences Centre and Department of Psychiatry, Dalhousie University, Halifax, NS
    J Psychiatry Neurosci 26:30-6. 2001
  5. ncbi Research funding for pain in Canada
    Mary E Lynch
    Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
    Pain Res Manag 14:113-5. 2009
  6. ncbi Waiting for treatment for chronic pain - a survey of existing benchmarks: toward establishing evidence-based benchmarks for medically acceptable waiting times
    Mary E Lynch
    Department of Psychiatry and Anestesia, Dalhousie University, Halifax, Nova Scotia, Canada
    Pain Res Manag 12:245-8. 2007
  7. ncbi A systematic review of the effect of waiting for treatment for chronic pain
    Mary E Lynch
    Department of Psychiatry and Anesthesia, Dalhousie University, Halifax, Nova Scotia, Canada
    Pain 136:97-116. 2008
  8. ncbi A case series of patients using medicinal marihuana for management of chronic pain under the Canadian Marihuana Medical Access Regulations
    Mary E Lynch
    Pain Management Unit, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada
    J Pain Symptom Manage 32:497-501. 2006
  9. ncbi The pharmacotherapy of chronic pain: a review
    Mary E Lynch
    Department of Psychiatry, Dalhousie University, Halifax, Canada
    Pain Res Manag 11:11-38. 2006
  10. ncbi Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study
    Mary Elizabeth Lynch
    Pain Management Unit, Queen Elizabeth II Health Sciences Centre and Department Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
    J Pain 6:644-9. 2005

Collaborators

Detail Information

Publications14

  1. ncbi Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design
    Mary Elizabeth Lynch
    Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
    Pain 103:111-7. 2003
    ..The results of this study support previous reports that indicate intravenous adenosine alleviates neuropathic pain and hyperalgesia...
  2. ncbi A review of the use of methadone for the treatment of chronic noncancer pain
    Mary E Lynch
    Pain Managemaent Unit, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
    Pain Res Manag 10:133-44. 2005
    ..The present review is intended to educate physicians interested in adding methadone to their armamentarium for assisting patients with moderate to severe pain...
  3. ncbi Compound heterozygosity in sodium channel Nav1.7 in a family with hereditary erythermalgia
    Mark E Samuels
    Département de Médicine, Centre de Recherche du CHUM, Local M 5226, Hopital Notre Dame, 1560 rue Sherbrooke Est, Montreal QC H2L 4M1, Canada
    Mol Pain 4:21. 2008
    ..This is the second reported study of potential compound heterozygosity for coding polymorphisms in Nav1.7, the first being in a patient with paroxysmal extreme pain disorder...
  4. ncbi Antidepressants as analgesics: a review of randomized controlled trials
    M E Lynch
    Queen Elizabeth II Health Sciences Centre and Department of Psychiatry, Dalhousie University, Halifax, NS
    J Psychiatry Neurosci 26:30-6. 2001
    ....
  5. ncbi Research funding for pain in Canada
    Mary E Lynch
    Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
    Pain Res Manag 14:113-5. 2009
    ..9 million. This is less than 1% of the total funding from the Canadian Institutes of Health Research and 0.25% of the total funding for health research...
  6. ncbi Waiting for treatment for chronic pain - a survey of existing benchmarks: toward establishing evidence-based benchmarks for medically acceptable waiting times
    Mary E Lynch
    Department of Psychiatry and Anestesia, Dalhousie University, Halifax, Nova Scotia, Canada
    Pain Res Manag 12:245-8. 2007
    ..This will facilitate advocacy for improved access to appropriate care for people suffering from chronic pain around the world...
  7. ncbi A systematic review of the effect of waiting for treatment for chronic pain
    Mary E Lynch
    Department of Psychiatry and Anesthesia, Dalhousie University, Halifax, Nova Scotia, Canada
    Pain 136:97-116. 2008
    ..Most important is the need to improve access to appropriate care for patients with chronic pain, an escalating public health care problem with significant human and economic costs...
  8. ncbi A case series of patients using medicinal marihuana for management of chronic pain under the Canadian Marihuana Medical Access Regulations
    Mary E Lynch
    Pain Management Unit, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada
    J Pain Symptom Manage 32:497-501. 2006
    ..Limitations of the study include self-selection bias, small size, and lack of a control group. The need for further study using controlled trials is discussed along with an overview of the MMAR program...
  9. ncbi The pharmacotherapy of chronic pain: a review
    Mary E Lynch
    Department of Psychiatry, Dalhousie University, Halifax, Canada
    Pain Res Manag 11:11-38. 2006
    ....
  10. ncbi Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study
    Mary Elizabeth Lynch
    Pain Management Unit, Queen Elizabeth II Health Sciences Centre and Department Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
    J Pain 6:644-9. 2005
    ....
  11. ncbi Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial
    Mary E Lynch
    Pain Management Unit, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
    Anesthesiology 103:140-6. 2005
    ..A double-blind, randomized, placebo-controlled 3-week study evaluated the efficacy of topical 2% amitriptyline, 1% ketamine, and a combination of both in treating patients with neuropathic pain...
  12. ncbi A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain
    M E Lynch
    Pain Management Unit, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia
    Clin J Pain 19:323-8. 2003
    ..This is a pilot study providing initial information regarding the use of novel topical preparations containing amitriptyline (AMI), ketamine (KET), and a combination of both in the treatment of neuropathic pain...
  13. ncbi Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
    Mary E Lynch
    Department Anesthesia, Psychiatry, Dalhousie University, Halifax, Canada
    Br J Clin Pharmacol 72:735-44. 2011
    ..The context of the need for additional treatments for chronic pain is reviewed. Further large studies of longer duration examining specific cannabinoids in homogeneous populations are required...
  14. ncbi The pharmacotherapy of chronic pain
    Mary E Lynch
    Pain Management Unit, Queen Elizabeth II Health Sciences Centre, Department of Anesthesiology, Psychiatry, and Pharmacology, Dalhousie University, 4th Floor Dickson Centre, Room 4086, Halifax, NS B3H 1V7, Canada
    Rheum Dis Clin North Am 34:369-85. 2008
    ..For moderate to severe pain, one would initiate a trial of chronic opioid earlier. Cannabinoids and topicals may also be appropriate as single agents or in combination...